Giordano Roberta, Balbo Marcella, Picu Andreea, Bonelli Lorenza, Berardelli Rita, Falorni Alberto, Ghigo Ezio, Arvat Emanuela
Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Turin, Ospedale Molinette, C.so Dogliotti 14 10126 Turin, Italy.
Eur J Endocrinol. 2006 Sep;155(3):421-8. doi: 10.1530/eje.1.02222.
In autoimmune polyglandular syndrome types 1, 2, and 4 primary adrenal insufficiency is present, but its diagnosis is often late. We investigated the function of the hypothalamic-pituitary-adrenal axis in a group of patients with autoimmune diseases (AP) without any symptoms and signs of hypoadrenalism.
In 10 AP and 12 normal subjects (NS), we studied cortisol (F), aldosterone (A), and DHEA responses to 0.06 microg adrenocorticotropin (ACTH) (1-24) followed by 250 microg, ACTH and F responses to human corticotropin-releasing hormone (hCRH; 100 microg) and insulin tolerance test (ITT) (0.1 UI/kg).
Basal F, A, DHEA, as well as urinary free cortisol and plasma renin activity levels in AP and NS were similar, whereas ACTH levels in AP were higher (P<0.05) than in NS. NS showed F, A, and DHEA response to both consecutive ACTH doses. In AP, the F, A, and DHEA responses to 250 microg ACTH were similar to those in NS, whereas the 0.06 microg ACTH dose did not elicit any significant response. The ACTH responses to hCRH and ITT in AP were higher (P<0.05) than in NS. The F response to hCRH in AP was lower (P<0.05) than in NS, whereas the F response to ITT in AP did not significantly differ from NS.
Enhancement of both basal and stimulated corticotrope secretion coupled with reduced adrenal sensitivity to low ACTH dose is present in AP patients without symptoms and signs of hypoadrenalism. This functional picture suggests that normal adrenal secretion is maintained due to corticotrope hyperfunction, suggesting the existence of some subclinical primary hypoadrenalism.
在1型、2型和4型自身免疫性多腺体综合征中存在原发性肾上腺功能不全,但其诊断往往较晚。我们研究了一组无肾上腺功能减退症状和体征的自身免疫性疾病(AP)患者下丘脑 - 垂体 - 肾上腺轴的功能。
在10名AP患者和12名正常受试者(NS)中,我们研究了皮质醇(F)、醛固酮(A)和脱氢表雄酮(DHEA)对0.06微克促肾上腺皮质激素(ACTH)(1 - 24)的反应,随后给予250微克ACTH,以及F对人促肾上腺皮质激素释放激素(hCRH;100微克)和胰岛素耐量试验(ITT)(0.1 UI/kg)的反应。
AP患者和NS的基础F、A、DHEA以及尿游离皮质醇和血浆肾素活性水平相似,而AP患者的ACTH水平高于NS(P<0.05)。NS对连续两次ACTH剂量均显示出F、A和DHEA反应。在AP患者中,对250微克ACTH的F、A和DHEA反应与NS相似,而0.06微克ACTH剂量未引起任何显著反应。AP患者对hCRH和ITT的ACTH反应高于NS(P<0.05)。AP患者对hCRH的F反应低于NS(P<0.05),而AP患者对ITT的F反应与NS无显著差异。
在无肾上腺功能减退症状和体征的AP患者中,基础和刺激状态下促肾上腺皮质激素分泌均增强,同时肾上腺对低剂量ACTH的敏感性降低。这种功能表现提示由于促肾上腺皮质激素功能亢进维持了正常的肾上腺分泌,提示存在一些亚临床原发性肾上腺功能减退。